Experts in heart failure clinical trials, including Scott Solomon and JoAnn Lindenfeld, discuss the importance of analyzing subgroups in trials. They emphasize the challenges in interpreting data, the impact of therapy, and the need for personalized medicine for better treatment outcomes.

Dr. JoAnn Lindenfeld, Director of Heart Failure at Vanderbilt Heart and Vascular Institute, joins fellows Richa Gupta and Jessica Huston for a deep dive into heart transplantation. They explore the intricacies of organ allocation and recipient selection, stressing the need for equitable processes. The discussion also highlights innovative strategies to expand the donor pool, including using hepatitis C positive hearts. Additionally, the team navigates the critical challenges post-surgery, covering the importance of immunosuppressive medications and long-term care strategies.

Special guests Melvin Echols, Nasrien Ibrahim, Vanessa Blumer, Wayne Batchelor, JoAnn Lindenfeld, and Mitchell Psotka join the podcast to discuss the importance of enrolling diverse populations in HF clinical trials. How can we target a more representative population?